Clinical trial
Impact of an Early Warning System on the Prognosis of Patients With Hematological Malignancies Receiving Intensive Chemotherapy With or Without Hematopoietic Cell Transplantation, a Multicenter Cluster Randomized Study
NCT06409767 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of an Early Warning System on the Prognosis of Patients With Hematological Malignancies Receiving Intensive Chemotherapy With or Without Hematopoietic Cell Transplantation, a Multicenter Cluster Randomized Study
- Lead sponsor
- University Hospital, Angers
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 10, 2025
- Completion date
- July 11, 2028
- Enrollment
- 2,224 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.